Posted on

How to Test the Quality of a Reishi Product

Confused about the many Ganoderma extract supplements in the market? How to check whether the Ganoderma product you’re taking now is good?

You may find many Ganoderma extract supplements in the market due to its increasing worldwide popularity. It ranges from Ganoderma coffee to Ganoderma extract powder. All these supplements are claimed to have significant healing effects.

However, we may or may not feel the claimed health benefits. Below are 5 factors you must consider when choosing Ganoderma herbal supplements.

1) Ganoderma extract or grinding

Some company simply grinds this herb into powder form. Some uses high technology extraction method to extract only its essences into powder form.

Extraction concentration can be as high as 16 to 1. That means, 1000kg of this fungus is extracted to only 60kg. One capsule of Ganoderma extract at 16 to 1 concentration is equivalent to 16 capsules of the grinded one.

Needless to say, Ganoderma herb supplement using extraction method is many times more effective and purer than grinding method.

2) Capsulated or log wood cultivation

Most Ganoderma products are capsulated (vacuum packing) cultivated using wooden crams and chemicals. This produces softer fruit body with less active components for effective health improvement.

Because of the chemicals used, some may even be contaminated with toxics and even heavy metals such as mercury.

Meanwhile, log wood cultivated Ganoderma is a few times more potent in its medicinal values. It is purer with higher content of beneficial active components.

However, this cultivation method is much more expensive in term of the space used and time required. So, many manufacturers prefer to use capsulated cultivated Ganoderma.

3) Ganoderma spore powder

Spore powder is the most precious part of Ganoderma herb with the most concentration of active components like Organic Germanium, Polysaccharides and Triterpenes.

Choose Ganoderma extract with spore powder for better results. Make sure the spore shell is broken to release its essences.

4) International quality certification

Of course, we would better select a manufacturer with experience and excellent production quality control. This ensures the quality consistence of their supplement product, all the time.

5) Percentage of Ganoderma extract

Some manufacturer includes a tiny fraction of Ganoderma into their herb supplement, mixed with other ingredients. As such, the healing effect is far less than the pure one.

However, some acclaimed pure Ganoderma extract may not be pure at all. Maybe 20% is Ganoderma and the rest is filler. This is another point of concern – the honesty and credibility of manufacturer.

How to test Ganoderma product

First, fill a glass with water and pour in some cooking oil such as olive oil.
  Ganoderma Test Start

Then, open up a Ganoderma extract capsule and spread some of its powder evenly on top of the oil surface.

The powder will float on the oil surface. Here comes the first test point.

 

See whether the extract powder can slowly penetrate the oil. This shows its ability to pass through fats and cholesterol clot in our blood vessel wall and cleanses it.

For second Ganoderma test point, leave it for around 10 days and take a look.
  Ganoderma Good

This is good Ganoderma extract. It blends evenly with the water after a few days.

The oil surface is clear of any mould. This means it has strong germ fighting ability.

 
 
Ganoderma Bad

This is not your choice of Ganoderma extract. It still floats on the oil surface.

Take a closer look and you can see mould on the surface. This one has weak germ fighting ability.

 

Now is the third test point for Ganoderma spores. Take a look at the bottom of the glass. The spore powder is the white substance deposited at the bottom.

  Ganoderma with Spore

This is what you want – Ganoderma spore powder, the most precious part of this medicinal herb.

 

 
 
Ganoderma without Spore

Ganoderma spore can hardly be seen. You can expect very less healing effects here.

 

For the final Ganoderma test point, cover the glass with transparent wrapper and leave it for as long as possible. The better Ganoderma extract can preserve mould-free environment for many years.

 

Other Ganoderma test

This is a simple and effective test method. You can also test for its taste. Pure Ganoderma taste very bitter.

For a more thorough test, you need to submit Ganoderma extract sample to the laboratory to test for heavy metals such as mercury, arsenic and lead. Test for steroids content too as it might be misused. Steroid harms your body for long term consumption.

Ganoderma is one of the few herb supplement that can be safely taken for long term. However, you must make sure you are taking the purest one.

 

Source:Ganoderma-for-health.com

We tried this with Fungi Health’s Reishi extract with the same results!

Posted on

Ganoderma Lucidium

Studies on Bioactive Substances and Medical Effects of REISHI

Reishi, the fruiting body of Mannentake, Ganoderma lucidum has been known in Japan, China, and other countries as a food and raw material for the development of drugs.  Recent studies have shown that that carcinostatic substance in Reishi is a polysaccharide, beta (1-3)- D – glucan. This polysaccharide seems to have promise as a new type of carcinostatic agent which might be useful in immunotherapy. Unlike chemicals used in chemotherapy, it has few toxic side effects because its effect is based on immunological enhancement in the host. Reishi also seems to contain other substances which reduce blood pressure, blood cholesterol, and blood sugar levels; and inhibit platelet aggregation, etc.

Recently, in vitro immunomodulating effects of Reishi extracts, and clinical study of micronized Reishi in Thai HIV and AIDS patients were attempted in Thailand. Some lanostane tri-terpenoids have been isolated from G. lucidum. These are highly oxidized compounds which show interesting biological activities.

Takashi Mizuno, Shizuoka University, Japan

Posted on

The Role of Reishi in Cancer Management.

red reishi

The Role of Reishi Supplements in Cancer Management

Ganoderma has been used as folk medicine since ancient times and it is a popular health food frequently promoted as a cancer cure. It is now well established from in vitro and animal studies that the polyshaccharide fraction of Ganoderma is largely responsible for its anti-tumor efficacy. Although there is yet no controlled clinical trials in humans for Ganoderma against cancer to date, the indications for its supplemental use can be indirectly supported with clinical trial data from comparable fungal polysaccharides because of a common final pathway of action mediated via beta-glucan receptor. Based on such indirect data, indications for Ganoderma use in cancer include supplementation a) to reduce side-effects during chemotherapy or radiotherapy, b) to prolonging survival and minimize metastasis, c) to improve quality of life, and d) to prevent occurrence or recurrence. In sum, although the cure of any cancer with Ganoderma alone is unlikely, it is probably beneficial under defined circumstances in most cases of malignancy.

Introduction

Ganoderma has been recognized traditionally and scientifically as potentially useful in the treatment of cancer, but there is a notable discrepancy with the publics frequent impression that ganoderma may be a cure for cancer and the lack of clinical trials demonstrating such efficacy. We intend to summarize the extent of available theoretical, experimental and clinical data for the use of Ganoderma Supplementation in cancer and outline its indications, especially in the context of clinical results from bioactively similar polysaccharide derived biological response modifiers (BRMs) from other fungi (Mizuno 1996).

Experimental Evidence of Ganodermas Potential in Cancer Treatment

Ikekawa et al. (1968) first reported on the efficacy of soluble extracts from Ganoderma in inhibiting transplanted sarcoma 180 in mice. This host-dependent anti-tumor activity has been subsequently confirmed to be from the polysaccharide fractions of Ganoderma (Sasaki et al., 1971). Multiple similar studies subsequently confirms this observation and anti-tumor efficacy of Ganoderma has been demonstrated from various species, at different stages of growth and using different solvents for extraction and different routes of administration. Anti-tumor activity has been demonstrated in vitro as well as in syngeneic tumor systems in animals. However, no human trials of Ganoderma against cancer in peer reviewed journals nor any controlled clinical trials in humans have yet been conducted or published.

From a theoretical point of view, it is important to note that other fungal polysaccharides of comparable structure and function as those found in Ganoderma have undergone rigorous clinical trials, including Lentinan, Sizofilan, PSK (Krestin), PSP. Since it is now increasingly clear that immunostimulatory bioactivity from most beta-glucan based compounds function via a similar beta-glucan receptor (Czop 1985), it has been possible to hypothesize that Ganoderma polysaccharides should function similarly (Chang, 1996). Clinical effects of various glucan based BRMs should therefore be comparable. Results from Lentinan, Sizofilan, PSK and PSP human trials demonstrated the efficacy of these glucan BRMs in prolonging survival in recurrent or advanced gastric and colon cancer, lung cancer and gynecological cancers, Data from such bioactively comparable compounds all suggest improved quality of life or survival for cancer patients may be possible with Ganoderma supplementation.

Indications and Evidence Supporting the Use of Ganoderma Supplementation in Cancer

Whilst some efficacy of Ganoderma in cancer is undoubted, it remains important to specify the various indications and cite the evidence to support its use. This can be discussed under four different circumstances:

A. As a supplement during chemotherapy or radiotherapy to reduce side-effects such as fatigue, loss of appetite, hair loss, bone marrow suppression and risk of infection. There are studies demonstrating Ganodermas efficacy against fatigue (Yang 1994), hair loss (Miyamoto et al. 1985), and bone marrow suppression (Jia et al. 1993) and the presence of similar clinical evidence for other glucan BRMs applied in the setting of cancer chemotherapy or radiotherapy (Shi 1993) lends further support to the supplementation of Ganoderma in combination with cytotoxic cancer therapies. The recommended dose should be in the range of five to ten grams of fruiting body or equivalent per day (Chang 1994).

B. As a supplement for cancer patients to enhance survival and reduce likelihood of metastasis. While only anecdotal data exists that ganoderma supplementation may enhance survival of cancer patients, this survival advantage has been demonstrated for a number of comparable glucan BRMs. Specifically, Lentinan use in advanced or recurrent gastric cancer demonstrated a significant life span prolongation advantage at 1, 2, 3 and 4 years in a randomized control trial (Taguchi 1987). Sizolan given together with chemotherapy enhanced survival of cervical cancers irrespective of stage in a prospective randomized controlled trial (Inoue et al. 1993), significantly enhanced survival (P.01) in lung cancer patients (Honma 1982) and improved five year survival of head and neck cancer from 73.4 to 86.7% was noted in another small study (Kimura et al. 1994). More appropriate for comparison to Ganoderma is perhaps PSK or PSP, which are orally administered. Mitomi et al. (1994) found significantly improved survival and disease-free survival (P=0.013) in resected colorectal cancer given PSK supplementation over three years when compared to control in a multi-center randomized controlled trial.

In an animal model, Ganoderma has been demonstrated to effectively prevent metastasis (Lee 1984), and these results are comparable to those of Lentinan (Suga 1994). Other glucan BRMs have been demonstrated to effectively prevent or suppress pulmonary metastasis of methylcholanthrene-induced sarcomas, human prostate cancer DU145M, and lymphatic metastasis of mouse leukemia P388 (Kobayashi et al. 1995). The recommended dose should be five to ten grams or more of fruiting body or equivalent per day, with a linear enhancement in efficacy expected up to 30 grams per day (Chang 1994).

C. As a supplement for cancer patients to improve quality of life. Again, only anecdotal information exists for Ganoderma in this situation but other oral glucan derivatives such as PSP has been found to be useful in improving quality of life in cancer patients (Yao 1993). Significantly, Ganoderma supplementation was noted to decrease pain in cancer patients (Kupin 1994). The recommended dose would be five to ten grams of fruiting body or equivalent per day (Chang 1994).

D. As a supplement for the prevention of occurrence or recurrence of cancer. Since immune stimulation, especially Natural Killer (NK) and Cytotoxic Lymphocyte (CTL) activation may be effective in the immune prevention of cancer by enhanced immune surveillance (Lotzova 1985), and Ganoderma has been demonstrated to enhance NK and CTL activity when administered orally (Won et al. 1989), it is thus a candidate for prevention of the occurrence or recurrence of cancer. Stavinoha et al. demonstrated the efficacy of Ganoderma in preventing the progression of microadenomatous growths in animals (Stavinoha 1993), and the efficacy of other glucan BRMs in primary and secondary cancer prevention have been similarly demonstrated in vitro, in vivo and in clinical trials.

Conclusion

Although Ganoderma and its derivatives are not pharmaceuticals and have not undergone rigorous clinical trials to be tested against cancer, there is abundant use in vitro, animal and indirect clinical evidence to support its supplemental use in cancer. Standardization in bioactive polysaccharide content and dosages will be necessary to assure its rational use, and clinical trials in select cancers with defined endpoints will confirm its efficacy.

Raymond Y. Chang, Meridian medical Group at the Institute of East-West Medicine and Department of Medicine, Cornell Medical College